Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin + Irinotecan vs Temozolomide in Glioblastoma (GLARIUS)
NCT00967330Phase 2Completed
- Sponsor
- Roche
- Start
- Jun 2010
- Primary completion
- Sep 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in glioblastoma (GBM), sponsored by Roche. Started Jun 2010; status: completed.
02
Drugs
bevacizumab
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT00967330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00967330.